CapsoVision, Inc. Common Stock
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. It offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps… Read more
CapsoVision, Inc. Common Stock (CV) - Total Assets
Latest total assets as of September 2025: $25.66 Million USD
Based on the latest financial reports, CapsoVision, Inc. Common Stock (CV) holds total assets worth $25.66 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CapsoVision, Inc. Common Stock - Total Assets Trend (2023–2024)
This chart illustrates how CapsoVision, Inc. Common Stock’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
CapsoVision, Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2024)
CapsoVision, Inc. Common Stock's total assets of $25.66 Million consist of 88.4% current assets and 11.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 55.5% |
| Accounts Receivable | $2.00 Million | 11.9% |
| Inventory | $2.63 Million | 15.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2023–2024)
This chart illustrates how CapsoVision, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CapsoVision, Inc. Common Stock's current assets represent 88.4% of total assets in 2024, a decrease from 89.2% in 2023.
- Cash Position: Cash and equivalents constituted 55.5% of total assets in 2024, down from 67.6% in 2023.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2023.
- Asset Diversification: The largest asset category is inventory at 15.7% of total assets.
CapsoVision, Inc. Common Stock Competitors by Total Assets
Key competitors of CapsoVision, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
CapsoVision, Inc. Common Stock - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - CapsoVision, Inc. Common Stock generates 0.70x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - CapsoVision, Inc. Common Stock is currently not profitable relative to its asset base.
CapsoVision, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.19 | 8.24 | 8.24 |
| Quick Ratio | 4.50 | 6.78 | 6.78 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $19.41 Million | $ 13.05 Million | $ 13.05 Million |
CapsoVision, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between CapsoVision, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.89 |
| Latest Market Cap to Assets Ratio | 9.41 |
| Asset Growth Rate (YoY) | -21.9% |
| Total Assets | $16.80 Million |
| Market Capitalization | $158.13 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values CapsoVision, Inc. Common Stock's assets at a significant premium ( 9.41x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: CapsoVision, Inc. Common Stock's assets decreased by 21.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for CapsoVision, Inc. Common Stock (2023–2024)
The table below shows the annual total assets of CapsoVision, Inc. Common Stock from 2023 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $16.80 Million | -21.94% |
| 2023-12-31 | $21.53 Million | -- |